Searchable abstracts of presentations at key conferences in endocrinology

ea0029n7 | (1) | ICEECE2012

Neutralization of Flightless I (Flii) using Flii-specific monoclonal antibodies accelerates impaired healing in diabetic wounds through improved cell proliferation

Ruzehaji Nadira , Wallace Hillary , Stacey Michael , Fitridge Robert , Cowin Allison

Ulceration is a common and severe complication of diabetes affecting 15% of the 200 million patients with diabetes worldwide. A significant proportion of these chronic wounds fail to respond to conventional treatment, hence major amputation is a feared outcome of diabetes. More than 60% of non-traumatic amputations in the western world are performed in the diabetic population. There exists a growing need for effective therapeutic agents to improve healing in these wounds.<...

ea0049ep150 | Endocrine tumours and neoplasia | ECE2017

Small pancreatic neuroendocrine incidentalomas: an observational prospective study

Villabona C , Busquets J , Martin L San , Planas A , Pelaez N , Fabregat J , Teule A , Peiro I

Background: Diagnosis of small pancreatic neuroendocrine incidentalomas (PNETs-I) is increasing during last years and often their management remains unclear.Objective: To describe our experience with patients with PNETs-I in our institution.Methods: Since March 2000, patients with non functioning PNETs-I ≤30 mm were evaluated in our center, prospectively. A descriptive analysis of all patients and a comparative study between ...

ea0008p18 | Cytokines and growth factors | SFE2004

Modulation of the circulating insulin-like growth factor system in patients with gastrointestinal inflammation

Baricevic I , Nedic O , Jones DR , Nikolic JA

Insulin-like growth factors (IGFs) and their binding proteins (IGFBPs) have important metabolic roles in the human body. IGFBP-3 (40 and 45 kD glycoforms) is the most abundant in serum, whereas IGFBP-2 (34 kD) and IGFBP-1 (29 kD) are present at lower concentrations.Most inflammatory diseases of the gastrointestinal tract are characterised by a cytokine- mediated inflammatory reaction, malnutrition and catabolism. The aim of this work was to detect possib...

ea0008go7 | (1) | SFE2004

Modulation of the circulating insulin-like growth factor system in patients with gastrointestinal inflammation

Baricevic I , Nedic O , Jones DR , Nikolic JA

Insulin-like growth factors (IGFs) and their binding proteins (IGFBPs) have important metabolic roles in the human body. IGFBP-3 (40 and 45 kD glycoforms) is the most abundant in serum, whereas IGFBP-2 (34 kD) and IGFBP-1 (29 kD) are present at lower concentrations.Most inflammatory diseases of the gastrointestinal tract are characterised by a cytokine- mediated inflammatory reaction, malnutrition and catabolism. The aim of this work was to detect possib...

ea0004p32 | Cytokines and growth factors | SFE2002

INSULIN-LIKE GROWTH FACTORS AND BINDING PROTEINS IN HUMAN EJACULATES

Nikolic J , Nedic O , Mihailovic N , Baricevic I

While previous studies have shown relatively low concentrations of insulin-like growth factors (IGF)in human ejaculates, high levels of IGF binding protein-2 (IGFBP-2)have been reported. The IGF/IGFBP system was investigated in ejaculates from thirty men aged 23-46 years consulting a fertility clinic. Volume, viscosity, total and motile sperm counts were estimated by standard methods and each subject consented for the specimen to be used in this study. Local Ethical Committee ...

ea0004p48 | Endocrine tumours and neoplasia | SFE2002

Prolactin, bilirubin and bile acid concentrations in breast cyst fluid

Sikri S , Szamel I , Ghilchik M , Parish D

Gross cystic disease of the breast is a condition afflicting 7% of western women and confers an increased risk of developing breast cancer. Biochemical analyses of breast cyst fluid (BCF) have allowed the identification of various components of BCF and the classification of breast cysts into type I and II cysts. Gross cystic disease fluid proteins (GCDFP) are a family of proteins found in BCF and include albumin, apolipoprotein D and prolactin inducible protein (PIP). It is pr...

ea0063p917 | Diabetes, Obesity and Metabolism 3 | ECE2019

Angiotensin-converting enzyme (ACE) gene I/D polymorphism and angiotensin II type 1 receptor (AGTR1) gene A1166C polymorphism and diabetic kidney disease

Vasilkova Volha , Pchelin Ivan , Borovets Yana , Naumenko Elena , Filiptsova Natallia , Mokhort Tatsiana

Background: Polymorphisms in angiotensin-converting enzyme (ACE) gene and angiotensin II type 1 receptor (AGTR1) gene have been assessed in previously multiple studies for association with diabetic nephropathy (DN), but results are still controversial.Aim: The aim of our study was to find out the role of ACE (I/D) and AGTR1 (A1166C) in genetic susceptibility of diabetic nephropathy in Belarusian population.Methods: The present case...

ea0014oc5.3 | Thyroid basic | ECE2007

Polarized plasma membrane targeting of the Na+/I symporter (NIS) is regulated by its carboxy terminus

Dohan Orsolya , Portulano Carla , Ginter Chris , Carrasco Nancy

The Na+/I− symporter (NIS), a glycoprotein expressed at the basolateral plasma membrane of thyroid epithelial cells, mediates active I− uptake for the biosynthesis of thyroid hormones and radioiodide transport for diagnosis and treatment in thyroid cancer. Our cloning of the NIS cDNA and generation of anti-NIS antibodies provided the basis to investigate the decrease in I− transport in thyroid cancer relative to hea...

ea0070aep572 | Pituitary and Neuroendocrinology | ECE2020

Baseline IGF-I values influence the effect of rhGH therapy on fat mass: Short, medium and long term study on adults with GH deficiency

Profka Eriselda , Rodari Giulia , Giacchetti Federico , Draghi Alessandro , Arosio Maura , Giavoli Claudia

Background: One of the main effects of growth hormone therapy (rhGH) in the adult GH deficient patient (AGHD) is to positively modify body composition, with a reduction in fat mass (BF) and an increase in total lean mass (LM). However, the response to replacement therapy is highly variable and, contrary to what described in children, the potential predictive factors are not yet known.Aim of the study: To assess the impact of basal IGF-I levels on variati...

ea0078p14 | Diabetes | BSPED2021

Level 3 Carbohydrate counting at diagnosis of Type I Diabetes Mellitus in children: How does it affect HbA1c?

Barber Wendy , Keeton Emma , Taylor Adele

Introduction: National guidance recommends Level 3 carbohydrate counting (L3CC) is delivered within 2 weeks of diagnosis of Type I Diabetes Mellitus (T1DM) (NICE, 2015). This was introduced at Derbyshire Children’s Hospital in 2017. This service evaluation aimed to assess the impact of this on patients’ blood glucose, by recording HbA1c levels at quarterly intervals over 6 months. Methods: A comparison of quarterly HbA1c in children that receiv...